SCHEMBL21189245

SCHEMBL21189245

CCOC(=O)c1cccc2c1OCC[C@@H]2NC(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TSHR P16473 2/20 0.38
TRPV1 Q8NER1 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
BRD4 O60885 2/20 0.37
CREBBP Q92793 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
MGAM O43451 1/20 0.36
AMY1A P0DUB6 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21189238 0.89 TSHR (0.41) MEN1KMT2ATSHRTRPV1L3MBTL1
SCHEMBL21189247 0.86 TRPV1 (0.40) KMT2ATRPV1L3MBTL1BRD4CREBBP
SCHEMBL21189246 0.82 TSHR (0.43) MEN1KMT2ATSHRL3MBTL1NPSR1
SCHEMBL21189287 0.82 MEN1 (0.37) MEN1KMT2ATSHRL3MBTL1NPSR1
SCHEMBL8113713 0.81 MLYCD (0.41) KMT2ANPSR1POLB
SCHEMBL21189240 0.80 TSHR (0.37) MEN1KMT2ATSHRTRPV1L3MBTL1
SCHEMBL21189239 0.80 TSHR (0.37) MEN1KMT2ATSHRTRPV1L3MBTL1
SCHEMBL8113376 0.79 NPC1 (0.43) KMT2AL3MBTL1BRD4CREBBPKDM4E
SCHEMBL7986840 0.76 BRD4 (0.48) KMT2ATRPV1L3MBTL1BRD4CREBBP
SCHEMBL29264385 0.76 BRD4 (0.48) KMT2ATRPV1L3MBTL1BRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS MEN1 1933/4885KMT2A 155/4885TSHR 3232/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS MEN1 1933/4885KMT2A 155/4885TSHR 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.